MXPA02002859A - Formulaciones para uso parenteral del fosfato de estramustina con propiedades farmacologicas mejoradas. - Google Patents

Formulaciones para uso parenteral del fosfato de estramustina con propiedades farmacologicas mejoradas.

Info

Publication number
MXPA02002859A
MXPA02002859A MXPA02002859A MXPA02002859A MXPA02002859A MX PA02002859 A MXPA02002859 A MX PA02002859A MX PA02002859 A MXPA02002859 A MX PA02002859A MX PA02002859 A MXPA02002859 A MX PA02002859A MX PA02002859 A MXPA02002859 A MX PA02002859A
Authority
MX
Mexico
Prior art keywords
formulations
pharmacological properties
parenteral use
estramustine phosphate
improved pharmacological
Prior art date
Application number
MXPA02002859A
Other languages
English (en)
Spanish (es)
Inventor
Lorena Muggetti
Original Assignee
Pharmacia Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia Spa filed Critical Pharmacia Italia Spa
Publication of MXPA02002859A publication Critical patent/MXPA02002859A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MXPA02002859A 1999-09-16 2000-08-03 Formulaciones para uso parenteral del fosfato de estramustina con propiedades farmacologicas mejoradas. MXPA02002859A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9921954.5A GB9921954D0 (en) 1999-09-16 1999-09-16 Formulations for parenteral use of estramustine phosphate with improved pharmacological properties
PCT/EP2000/007679 WO2001019338A1 (en) 1999-09-16 2000-08-03 Formulations for parenteral use of estramustine phosphate with improved pharmacological properties

Publications (1)

Publication Number Publication Date
MXPA02002859A true MXPA02002859A (es) 2003-07-21

Family

ID=10861066

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02002859A MXPA02002859A (es) 1999-09-16 2000-08-03 Formulaciones para uso parenteral del fosfato de estramustina con propiedades farmacologicas mejoradas.

Country Status (20)

Country Link
EP (1) EP1212040A1 (ja)
JP (1) JP2003509355A (ja)
KR (1) KR20020059405A (ja)
CN (1) CN1177583C (ja)
AU (1) AU777763B2 (ja)
BR (1) BR0014063A (ja)
CA (1) CA2385063A1 (ja)
CZ (1) CZ2002943A3 (ja)
EA (1) EA005308B1 (ja)
GB (1) GB9921954D0 (ja)
HK (1) HK1047227A1 (ja)
HU (1) HUP0202621A2 (ja)
IL (1) IL148409A0 (ja)
MX (1) MXPA02002859A (ja)
NO (1) NO20021306L (ja)
NZ (1) NZ517631A (ja)
PL (1) PL353954A1 (ja)
SK (1) SK3452002A3 (ja)
WO (1) WO2001019338A1 (ja)
ZA (1) ZA200201743B (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7658913B2 (en) 2005-11-28 2010-02-09 Verrow Pharmaceuticals, Inc. Compositions useful for reducing nephrotoxicity and methods of use thereof
WO2012037704A1 (en) 2010-09-21 2012-03-29 Telefonaktiebolaget L M Ericsson (Publ) Air-interface timing synchronization sharing
WO2019094819A2 (en) * 2017-11-09 2019-05-16 Abon Pharmaceuticals, Llc Intravenous delivery systems for chemotherapy drugs

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59108800A (ja) * 1982-12-13 1984-06-23 Japan Atom Energy Res Inst 誘導ミサイル作用および制癌剤の徐放性機能をもつ微粒子
KR0166088B1 (ko) * 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5602112A (en) * 1992-06-19 1997-02-11 Supergen, Inc. Pharmaceutical formulation
GB9419153D0 (en) * 1994-09-22 1994-11-09 Erba Carlo Spa Estramustine formulations with improved pharmaceutical properties
US20020039594A1 (en) * 1997-05-13 2002-04-04 Evan C. Unger Solid porous matrices and methods of making and using the same

Also Published As

Publication number Publication date
EA200200369A1 (ru) 2002-08-29
KR20020059405A (ko) 2002-07-12
CA2385063A1 (en) 2001-03-22
CZ2002943A3 (cs) 2002-08-14
JP2003509355A (ja) 2003-03-11
ZA200201743B (en) 2003-05-28
IL148409A0 (en) 2002-09-12
WO2001019338A1 (en) 2001-03-22
CN1374858A (zh) 2002-10-16
HUP0202621A2 (hu) 2002-12-28
EA005308B1 (ru) 2004-12-30
PL353954A1 (en) 2003-12-15
SK3452002A3 (en) 2002-08-06
NO20021306L (no) 2002-04-24
AU777763B2 (en) 2004-10-28
CN1177583C (zh) 2004-12-01
NZ517631A (en) 2004-01-30
GB9921954D0 (en) 1999-11-17
AU6836300A (en) 2001-04-17
EP1212040A1 (en) 2002-06-12
NO20021306D0 (no) 2002-03-15
BR0014063A (pt) 2004-06-29
HK1047227A1 (zh) 2003-02-14

Similar Documents

Publication Publication Date Title
AU2754700A (en) Busy-wait-free synchronization
IL148419A0 (en) Benzodiazepine derivatives, the production and use thereof
IL144281A0 (en) Multiple fuel vehicle
HK1044016A1 (en) Cellulignin fuel
IL150337A0 (en) Phenylpiperazinyl derivatives
EG22324A (en) Fifth generation draw line
PL351241A1 (en) Pharmacological compounds
GB2355214B (en) Integrated production system
MXPA02002859A (es) Formulaciones para uso parenteral del fosfato de estramustina con propiedades farmacologicas mejoradas.
GB9928891D0 (en) Synchronizer
IL132619A0 (en) Linked lists
HK1045698A1 (zh) 阿維菌素衍生物
GB9921958D0 (en) Formulations for parenteral use of estramustine phosphate and sulfoalkylether-cyclodextrins
GB9922125D0 (en) Phosphodiesterase enzymes
AU3710300A (en) Self-locking console latch
EP1236736A4 (en) 2-AMINOPURINDERIVATE
TW435204U (en) Marking-type injector
AU1301500A (en) Lock
AU5424099A (en) Rail with integrated supports
TW435537U (en) Improved structure for anti-thieving flower lock set
TW422240U (en) Knock set for anti-thieving lock
AUPQ043799A0 (en) Direct reduction with hydrogen
PL337565A1 (en) Elexctromagnetic bolt-type lock
TW397108U (en) Structure improvement for the lock set
TW376716U (en) Improvement of the swivel armrest